Eli Lilly Bolsters Metabolic Portfolio with Evotec and Abbisko Collaborations

By Lucy Haggerty

Pharma Deals Review: Vol 2022 Issue 1 (Table of Contents)

Published: 27 Jan-2022

DOI: 10.3833/pdr.v2022.i1.2665     ISSN: 1756-7874

Section: Research & Development



Eli Lilly has entered two key collaboration deals on the same day in a bid to expand its metabolic portfolio...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details